Eargo (EAR) stock forecast for 2022
Last update: September 23, 2022 (11:35)Sector: Healthcare
The share price of Eargo, Inc. (EAR) now
What analysts predict:: $2
52-week high/low: $10.63 / $0.67
50/200 Day Moving Average: $1.445 / $3.133
This figure corresponds to the average price over the previous 50/200 days. For Eargo stocks, the 50-day moving average is the support level today.
For Eargo stocks, the 200-day moving average is the resistance level today.
Are you interested in Eargo stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Eargo stock price in 2022. How much will one Eargo share be worth in 2022?
Is it worth taking profit / loss on Eargo stock now or waiting? What are analysts' forecasts for Eargo stock?
We forecast Eargo stock performance using neural networks based on historical data on Eargo stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
The Eargo stock prediction results are shown below and presented as a graph, table and text information.
Eargo stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Eargo analysts is $2.
Today 200 Day Moving Average is the resistance level (3.133 $).
50 Day Moving Average is the support level (1.445 $).
Historical and forecast chart of Eargo stock
The chart below shows the historical price of Eargo stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Eargo stock price can be found in the table below.
Eargo (EAR) Forecast for 2022
Eargo information and performance
Eargo is an American medical device manufacturer dedicated to improving the quality of life for people with hearing loss. The company developed the Eargo solution to create a hearing aid that consumers will truly want to use. The company’s innovative product and go-to-market approach addresses the key challenges of traditional hearing aid adoption, including social stigma, affordability and cost. The company believes its Eargo hearing aids are the only, virtually invisible, rechargeable, fully integrated in the ear canal, FDA-certified Class I device for the treatment of hearing loss. The rapid pace of innovation is driven by deep industry and technical expertise in mechanical engineering, product design, audio processing, clinical and auditory science, consumer electronics and embedded software development, and is supported by a strategic intellectual property portfolio.
1600 TECHNOLOGY DRIVE, 6TH FLOOR, SAN JOSE, CA, US
Market Capitalization: 53 599 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -184 014 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.683
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 17.14
Enterprise Value (EV) /Revenue
EV To EBITDA: -0.342
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 39411000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Eargo price target for 2021 by month
Target values for the price of one Eargo share for Oct 2022.
Pessimistic target level: 1.12
Optimistic target level: 1.56
Target values for the price of one Eargo share for Nov 2022.
Pessimistic target level: 1.09
Optimistic target level: 1.58
Target values for the price of one Eargo share for Dec 2022.
Pessimistic target level: 1.03
Optimistic target level: 1.49
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.